הנחיות קליניות מעודכנות לטיפול תרופתי באנשים חסרי האנזים G6PD
קווים מנחים, המלצות וניירות עמדה לטיפול תרופתי באנשים חסרי האנזים G6PD
How I treat childhood CML
11:39
סגור לתגובות על How I treat childhood CML
Chronic myeloid leukemia (CML) is composed of 3% of pediatric leukemias,
Diagnosis and Management of Aplastic Anemia
10:55
סגור לתגובות על Diagnosis and Management of Aplastic Anemia
Aplastic anemia remains a diagnosis of exclusion. Our ability to reliably diagnose, and therefore exclude, a variety of
How I treat autoimmune lymphoproliferative syndrome
16:40
סגור לתגובות על How I treat autoimmune lymphoproliferative syndrome
Autoimmune lymphoproliferative syndrome (ALPS) represents a failure of apoptotic mechanisms to maintain lymphocyte homeostasis, permitting accumulation of lymphoid
Guidelines for the diagnosis and management of hereditary spherocytosis – 2011 update
11:32
סגור לתגובות על Guidelines for the diagnosis and management of hereditary spherocytosis – 2011 update
Guidelines on hereditary spherocytosis (HS) published in 2004 (Bolton-Maggs et al, 2004) are here replaced to reflect changes in current
How I treat hemophagocytic lymphohistiocytosis
16:36
סגור לתגובות על How I treat hemophagocytic lymphohistiocytosis
Hemophagocytic lymphohistiocytosis (HLH) is a syndrome of pathologic immune activation, occurring as either a familial disorder or a
How I treat hemophagocytic lymphohistiocytosis
12:21
סגור לתגובות על How I treat hemophagocytic lymphohistiocytosis
BLOOD, 13 OCTOBER 2011 , VOLUME 118, NUMBER 15
How I treat extramedullary acute myeloid leukemia
17:35
סגור לתגובות על How I treat extramedullary acute myeloid leukemia
Richard L. Bakst, Martin S. Tallman, Dan Douer and Joachim Yahalom
Blood 2011 118:3785-3793
